- Breast Cancer
- Cancer Control
- Chemotherapy
- Diagnostics and Screening
- Gastrointestinal Cancers
- Genitourinary Cancers
- Geriatric Oncology
- Gynecological Oncology
- Head, Neck and Thyroid Cancers
- Hematology
- Hematological Malignancies
- Imaging
- Lung Cancer
- Neurological Cancers
- Pediatric Oncology
- Radiotherapy
- Sarcomas and Melanomas
- Supportive Oncology
Specialties
Fri, 2012-06-01
Thu, 2012-06-14
Thu, 2012-06-28
Latest Testimonial
"Very well done and exciting. Congratulations."
Professor of Medicine and Director
Emili Montserrat
Institute of Hematology and Oncology at the Hospital Clinic of Barcelona
Transarterial docetaxel-cisplatin effective for NSCLC
U.S. may speed approval of 'breakthrough' drugs
FDA provides update on Revlimid
High-risk breast cancer may recur at similar rates after lumpectomy and...
Maintenance with lenalidomide delays myeloma reappearance
Take second-look at node-negative or DCIS breast pathology: study
Vitamins B and E may relieve benign persistent breast pain
Stem cell allografts effective for high-risk AML subtype
Translation inhibitors show potential in breast cancer models
CNK1 PH domain investigated as a target for KRas-mutant cancer
Touch Oncology
Immune Thrombocytopenia
The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia
Roberto Stasi, Elizabeth Rhodes, Reuben Benjamin, Hubertus Buyck, Fenella Willis, Muriel S Shannon, Edward C Gordon-Smith
European Oncology & Haematology, 2011;7(1):63-70
Head and Neck Cancer
Cetuximab in the Treatment of Locally Advanced Head and Neck Cancer
Rainald Knecht
European Oncology & Haematology, 2011;7(1):16-23
Mediastinal Staging
The Challenge of Mediastinal Staging
Loris Ceron, Lucio Michieletto, Andrea Zamperlin, Laura Mancino
European Oncology & Haematology, 2011;7(1):31-35
Pharmacologic Symptomatic Treatment
Breakthrough Pain in Cancer Patients— Pharmacologic Symptomatic Treatment
Marco Pappagallo
US Oncology & Hematology, 2011;7(1):17-21
Latest News
Editor's choice
Also in Editor's Choice











